Hui Gao

Hui Gao


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2016 in Molecules
Verified
Journal Article
Open access
PDF file
YMYulu Ma
Yulu Ma
XZXi Zheng
Xi Zheng
HGHui Gao
Hui Gao
CWChunping Wan
Chunping Wan
GRGaoxiong Rao
Gaoxiong Rao
ZMZewei Mao
Zewei Mao
A series of novel hybrid compounds between benzofuran and N-aryl piperazine have been synthesized and screened in vitro for anti-inflammatory activity in lipopolysaccharide (LPS)-stimulated RAW-264.7 macrophages and for anticancer activity against three human tumor cell lines. The results demonstrated that derivative 16 not only had inhibitory effect on the generation of NO (IC50 = 5.28 μM), but also showed satisfactory and selective cytotoxic activity against human lung cancer line (A549) and gastric cancer cell (SGC7901) (IC50 = 0.12 μM and 2.75 μM, respectively), which was identified as the most potent anti-inflammatory and anti-tumor agent in this study.

7 April 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
YTYanling Tang
Yanling Tang
MLMinxin Li
Minxin Li
HGHui Gao
Hui Gao
GRGaoxiong Rao
Gaoxiong Rao
ZMZewei Mao
Zewei Mao
An efficient method was developed for synthesis of benzoxazoles by Cu-catalyzed intramolecular O-arylation of o-halobenzanilides in water. This strategy provides several advantages, such as high yields, water as a green solvent and functional groups tolerance.

8 May 2020 in Current Organic Synthesis
Verified
Journal Article
Closed access
PDF file
YTYan-Ling Tang
Yan-Ling Tang
YLYong-Kun Li
Yong-Kun Li
MLMin-Xin Li
Min-Xin Li
HGHui Gao
Hui Gao
XYXiao-Bi Yang
Xiao-Bi Yang
ZMZewei Mao
Zewei Mao
Background: Infection is a global threat to human health, and there is an urgent need to develop new effective antibacterial drugs to treat bacterial infections. Objective: To study the antibacterial activity of piperazine substituted chalcone sulphonamides. Materials and Methods: A series of novel piperazine substituted chalcone sulphonamides have been prepared, and in vitro antibacterial activity against Staphylococcus aureus, Bacillus subtilis and Escherichia coli strains were evaluated. Results: The results showed that derivatives 6a, 6c and 6h displayed good antibacterial activity against Bacillus subtilis with MIC values of 4.0-8.0 mg/mL. Conclusion: Piperazine substituted chalcone sulphonamides may be used as potential antibacterial agents.